GLUE News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-06 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-06-11 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2026-05-07 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-03-17 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-02-10 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2026-01-09 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2026-01-07 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2026-01-07 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2025-12-16 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2025-11-06 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2025-09-15 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 1.01,7.01,9.01. |
| 2025-08-07 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-06-13 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2025-05-08 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2025-03-20 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2025-01-10 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2024-12-13 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2024-12-05 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2024-11-07 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-10-28 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 1.01,7.01,9.01. |
| 2024-08-08 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02. |
| 2024-06-27 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2024-06-12 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2024-05-30 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2024-05-16 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2024-05-09 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2024-05-02 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2024-03-14 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01. |
| 2024-01-08 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2023-11-09 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-10-26 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2023-10-17 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 1.01,7.01,8.01. |
| 2023-08-10 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-07-26 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2023-06-14 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 5.03,5.07,9.01. |
| 2023-05-11 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-03-23 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2023-03-16 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2023-01-09 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2022-11-10 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-10-24 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2022-08-11 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-06-15 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2022-05-11 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-03-29 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-01-10 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2021-12-15 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 1.01,2.03. |
| 2021-11-12 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2021-08-12 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2021-06-28 | Current report | SEC filing | Monte Rosa Therapeutics, Inc. filed Form 8-K | Monte Rosa Therapeutics, Inc. filed Form 8-K covering items 5.03,9.01. |